My mum has recently had a recurrence (3 small tumours, around the pelvis and bladder) after only a 5/6 month remission. It is her first recurrence. She is 64 years old and was diagnosed 3a in October of last year.
She has been in considerable pain over the last few weeks, and has decided to undergo weekly Taxol, which she is due to start next week. She was also offered CAELYX as an alternative, but she decided on Taxol as people seem to agree that this might be more effective.
We asked her Oncologist about possible clinical trials and we were referred to one at Barts hospital (UK), involving weekly Taxol with SARACATANIB.
We are really anxious and worried though because to go on the trial means delaying treatment (possibly by 2/3 more weeks) until she can be seen at Barts and assessed for the trial. She would not qualify for the trial is she started the normal Taxol regime (which she is booked in for) at her normal hospital (Southend).
Do you think it is safe to wait for the possiblity of being included on a trial? What are the risks? Has anyone heard of SARACATANIB, and what is it like? Apparently, it is a phase 2 trial.
If anyone can offer any advice as to what we should do, it would be greatly appreciatted.
We are desperately worried as to what decisions we have and what we should choose for my mum. Her Oncologist has been very helpful but at this stage it is really up to my mum, but she is very worried about delaying treatment.